Martin, Miguel <br/><br/>
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.  [electronic resource] 

 -  Breast cancer research : BCR  Apr 2014 
 - R38 p.  digital 
<br/><br/> Publication Type: Journal Article; Validation Study 
<br/><br/><label>ISSN: </label>1465-542X 
<br/><br/><label>Standard No.: </label>10.1186/bcr3642  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents, Hormonal--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Clinical Trials, Phase III as Topic<br/>Cyclophosphamide--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Lymphatic Metastasis<br/>Multicenter Studies as Topic<br/>Outcome Assessment, Health Care--methods<br/>Paclitaxel--administration & dosage<br/>Prospective Studies<br/>Randomized Controlled Trials as Topic<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Reproducibility of Results<br/>Retrospective Studies